Fmc Corp. (FMC)
NYSE:FMC
Want to see FMC full AI Analyst Report?
Earnings Data
Report Date
Aug 05, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.24Last Year’s EPS
0.69Same Quarter Last Year
Based on 12 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call presented a balanced picture: the company beat Q1 guidance, showed meaningful growth in new active ingredients (sales doubled Y/Y), secured regulatory approval for Isoflex in the EU, and has concrete plans and partial line-of-sight to achieve targeted 2026 debt paydown. However, FMC faces material near-term headwinds including lower partner-related revenues, mid-single-digit to double-digit declines in Q2 and full-year EBITDA and EPS, elevated interest expense and leverage, negative Q1 free cash flow, and ongoing cost/tariff uncertainties. Management expects the first half to be an earnings trough with sequential improvement in H2 and stronger results in 2027, but execution risk remains.Company Guidance
Q1 Sales and Beat vs Guidance
First quarter sales of $762 million were $12 million above the midpoint of guidance. Sales were down 4% year-over-year but up 1% on a like-for-like basis after excluding India.
Strong Q1 EBITDA and EPS vs Guidance
Adjusted Q1 EBITDA was $72 million, $17 million higher than the high end of guidance. Adjusted loss per share was $(0.23), $0.15 better than the guidance midpoint.
Branded and Volume Growth
FMC-branded sales grew 6% on a like-for-like basis; overall volume grew 2% in Q1 and FX provided a 5% tailwind to sales.
New Active Ingredients Momentum
Sales of new active ingredients doubled year-over-year in Q1 (100% growth), driven by Isoflex, fluindapyr and Dodhylex; management expects continued momentum and launches beginning in 2027.
Isoflex EU Approval — Strategic Win
Received EU regulatory approval for Isoflex active (first new herbicide approved in EU since 2019), opening access to >55 million planted hectares in cereals, corn, oilseed rape and potato with potential preregistration upside in Italy, Germany, France and Spain.
Progress Toward $1B Debt Paydown
Company targets roughly $1 billion of debt reduction in 2026. India commercial business sale is in late stages (expect definitive agreement in May). Management cites ~ $700 million of 'line-of-sight' proceeds currently in advanced negotiations (India, licensing, molecules, real estate).
Liquidity and Revolver Secured
Revolver amendment maintains $2 billion capacity (maturity June 2028) and adds collateral package (~$6 billion direct liens; up to ~$9 billion with guarantees). New secured leverage covenant set at 3.5x trailing EBITDA; secured leverage would have been ~1.3x at 3/31.
FMC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
FMC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 29, 2026 | $14.65 | $15.38 | +4.98% |
Feb 04, 2026 | $16.91 | $13.60 | -19.55% |
Oct 29, 2025 | $28.74 | $15.37 | -46.52% |
Jul 30, 2025 | $40.19 | $37.96 | -5.54% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Fmc Corp. (FMC) report earnings?
Fmc Corp. (FMC) is schdueled to report earning on Aug 05, 2026, After Close (Confirmed).
What is Fmc Corp. (FMC) earnings time?
Fmc Corp. (FMC) earnings time is at Aug 05, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is FMC EPS forecast?
FMC EPS forecast for the fiscal quarter 2026 (Q2) is 0.24.